Treatment of human fascioliasis with triclabendazole: good news

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 102, Issue 5, 2008, Pages 508-

  Curtale, Filippo ^a  

^a Agenzia di Sanita Pubblica della Regione Lazio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRICLABENDAZOLE;

BOLIVIA; DISEASE TRANSMISSION; DRUG CHOICE; DRUG INDUSTRY; DRUG MANUFACTURE; EGYPT; ENDEMIC DISEASE; FASCIOLA; FASCIOLIASIS; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH PERSONNEL ATTITUDE; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; LETTER; MEDICAL DECISION MAKING; PATHOGENESIS; PERU; PREVALENCE; PUBLIC HEALTH PROBLEM; PUBLIC HEALTH SERVICE; VIET NAM; WORLD HEALTH ORGANIZATION; YEMEN;

ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; DRUG INDUSTRY; FASCIOLIASIS; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; PUBLIC HEALTH;

EID: 41749118925     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.02.002     Document Type: Letter

References (5)

1. Chen M.G., and Mott K.E. Progress in assessment of morbidity due to Fasciola hepatica infection: a review of recent literature. Trop. Dis. Bull. 87 (1990) R1-R37
2. Curtale F. Treatment of fascioliasis in human infections: a reply. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 187-188
3. Curtale F., Hassanein Y.A.W., and Savioli L. Control of human fascioliasis by selective chemotherapy: design, cost and effect of the first public health, school-based intervention implemented in endemic areas of the Nile Delta. Trans. R. Soc. Trop. Med. Hyg. 99 (2005) 599-609
4. Farag H.F., Barakat R.M.R., Ragab M., and Omar E. A focus of human fascioliasis in the Nile Delta, Egypt. J. Trop. Med. Hyg. 82 (1979) 188-190
5. Mas-Coma S., Esteban J.G., and Bargues M.D. Epidemiology of human fascioliasis: a review and proposed new classification. Bull. World Health Organ. 77 (1999) 340-346